Emeis Stock Rises 2.24% Against a Declining CAC 40
On Wednesday, Emeis shares increased by 2.24% to €13.69, amid a downturn in the CAC 40, which fell by 0.63% during the session. This rebound comes after a challenging week for the stock, which saw a decline of nearly 3% over seven days. The next key event to watch will be the release of the Q1 2026 revenue figures, scheduled for May 6.
This morning, Emeis shares are trading at €13.69, surpassing their 20-day moving average of €13.51. However, the stock remains below its 50-day moving average of €14.07, indicating a still fragile medium-term dynamic. Over three months, the stock has declined by 6.17%, although its annual performance remains strong at 27.61%.
From a technical analysis perspective, the RSI is at 47, a neutral zone indicating neither overbought nor oversold conditions. The price is positioned in the middle of its Bollinger Bands (lower band at €12.21, upper band at €14.82), confirming no strong directional signals at this stage. The most relevant support threshold is at €12.26, while resistance is formed at €15.12. Today's rebound brings the stock above its 200-day moving average of €13.44, a level often considered by traders as a long-term trend indicator.
Emeis' Performance Contrasts with Paris Market Trends
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Emeis' advance contrasts with the overall tone of the Parisian market. The CAC 40 is down by 0.63% at 8,275 points, while the SBF 120 has dropped by 0.53%. Meanwhile, the DAX is roughly stable in Frankfurt, showing a slight increase of 0.05%. This divergence highlights the unique dynamics of the stock, which has a very low beta (0.09) indicating limited correlation with major indices.
In the European healthcare sector, Sanofi also saw a rise of 1.05%, while UCB remained stagnant. The upcoming release of first-quarter revenue on May 6 will be the next catalyst that could provide renewed visibility into the operational trajectory of the company. Until then, a monthly volatility of 17.19% suggests the possibility of significant intraday movements, in a context of limited trading volumes on the stock.
SectorServices et infrastructure de santé›Etablissements de santé / EHPAD
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: 9M 2026
Key reported figures
Revenue: 4 543 millions d'euros
Quarterly revenue: 4 543 millions d'euros
Revenue growth: 3,5 %
Guidance from the release
« Les tendances observées lors des 9 premiers mois de l'année 2026 confortent emeis dans l'atteinte des objectifs pour 2026, objectifs par ailleurs relevés fin juillet. »
Risks mentioned
Health crises linked to flu outbreaks and heat waves requiring proactive management
Macroeconomic uncertainty and risk of return to inflation impacting operating expenses
Dependency on continued execution of operational efficiency programs such as the Boost initiative in France
Opportunities identified
Strong like-for-like revenue growth of +6.0% driven by improved occupancy rates and favorable pricing effects
Average occupancy rate now above 90% with +2.9 pts annual increase, particularly strong in nursing homes (+3.1 pts)
Structural demographic tailwind with European senior population aged 85+ expected to grow over 30% in next 10 years
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
